|
1
|
Tocci A and Forte L: Mesenchymal stem
cell: Use and perspectives. Hematol J. 4:92–96. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Quarto R, Mastrogiacomo M, Cancedda R,
Kutepov SM, Mukhachev V, Lavroukov A, Kon E and Marcacci M: Repair
of large bone effects with the use of autologous bone marrow
stromal cells. N Engl J Med. 344:385–386. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mauney JR, Volloch V and Kaplan DL: Role
of adult mesenchymal stem cells in bone tissue engineering
applications: Current status and future prospects. Tissue Eng.
11:787–802. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tran TS, Kolodkin AL and Bharadwaj R:
Semaphorin regulation of cellular morphology. Annu Rev Cell Dev
Biol. 23:263–292. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hinck L: The versatile roles of ‘axon
guidance’ cues in tissue morphogenesis. Dev Cell. 7:783–793. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Behar O, Golden JA, Mashimo H, Schoen FJ
and Fishman MC: Semaphorin III is needed for normal patterning and
growth of nerves, bones and heart. Nature. 383:525–528. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang Y, Singh MK, Degenhardt KR, Lu MM,
Bennett J, Yoshida Y and Epstein JA: Tie2Cre-mediated inactivation
of plexinD1 results in congenital heart, vascular and skeletal
defects. Dev Biol. 325:82–93. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Reidy KJ, Villegas G, Teichman J, Veron D,
Shen W, Jimenez J, Thomas D and Tufro A: Semaphorin3a regulates
endothelial cell number and podocyte differentiation during
glomerular development. Development. 136:3979–3989. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Neufeld G, Sabag AD, Rabinovicz N and
Kessler O: Semaphorins in angiogenesis and tumor progression. Cold
Spring Harb Perspect Med. 2:a0067182012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hota PK and Buck M: Plexin structures are
coming: Opportunities for multilevel investigations of semaphorin
guidance receptors, their cell signaling mechanisms, and functions.
Cell Mol Life Sci. 69:3765–3805. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Maione F, Capano S, Regano D, Zentilin L,
Giacca M, Casanovas O, Bussolino F, Serini G and Giraudo E:
Semaphorin3A overcomes cancer hypoxia and metastatic dissemination
induced by antiangiogenic treatment in mice. J Clin Invest.
122:1832–1848. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Takamatsu H and Kumanogoh A: Diverse roles
for semaphorin-plexin signaling in the immune system. Trends
Immunol. 33:127–135. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chakraborty G, Kumar S, Mishra R, Patil TV
and Kundu GC: Semaphorin 3A suppresses tumor growth and metastasis
in mice melanoma model. PLoS One. 7:e336332012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Serini G, Maione F, Giraudo E and
Bussolino F: Semaphorins and tumor angiogenesis. Angiogenesis.
12:187–193. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Maione F, Capano S, Regano D, Zentilin L,
Giacca M, Casanovas O, Bussolino F, Serini G and Giraudo E:
Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination
induced by antiangiogenic treatment in mice. J Clin Invest.
122:1832–1848. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gaur P, Bielenberg DR, Samuel S, Bose D,
Zhou Y, Gray MJ, Dallas NA, Fan F, Xia L, Lu J and Ellis LM: Role
of class 3 semaphorins and their receptors in tumor growth and
angiogenesis. Clin Cancer Res. 15:6763–6770. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fukuda T, Takeda S, Xu R, Ochi H, Sunamura
S, Sato T, Shibata S, Yoshida Y, Gu Z, Kimura A, et al: Sema3A
regulates bone-mass accrual through sensory innervations. Nature.
497:490–493. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hayashi M, Nakashima T, Taniguchi M,
Kodama T, Kumanogoh A and Takayanagi H: Osteoprotection by
semaphorin 3A. Nature. 485:69–74. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang H, Cheng JQ, Huang Q, Yang J, Shen
B, Zhou ZK, Kang PD, Lian YY and Pei FX: Increasing alcohol-induced
osteogenesis of human bone marrow-derived mesenchymal cells using
siRNA transient suppression of peroxisome proliferator activated
receptor gamma: An in vitro experiment study. Zhonghua Yi Xue Za
Zhi 88: 2603–2608, 2008. Zhonghua Yi Xue Za Zhi 88: 2603–2608,
2008. 88: 2603–2608, 2008:2603-2608, 2008–2608, 2008. 2008.(In
Chinese).
|
|
20
|
Farh KK, Grimson A, Jan C, Lewis BP,
Johnston WK, Lim LP, Burge CB and Bartel DP: The widespread impact
of mammalian MicroRNAs on mRNA repression and evolution. Science.
310:1817–1821. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cai Y, Xu MJ, Teng X, Zhou YB, Chen L, Zhu
Y, Wang X, Tang CS and Qi YF: Intermedin inhibits vascular
calcification by increasing the level of matrix
gamma-carboxyglutamic acid protein. Cardiovasc Res. 85:864–873.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim BS, Kim YC, Zadeh H, Park YJ, Pi SH,
Shin HS and You HK: Effects of the dichloromethane fraction of
Dipsaci Radix on the osteoblastic differentiation of human alveolar
bone marrow-derived mesenchymal stem cells. Biosci Biotechnol
Biochem. 75:13–19. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bates D, Taylor GI, Minichiello J, Farlie
P, Cichowitz A, Watson N, Klagsbrun M, Mamluk R and Newgreen DF:
Neurovascular congruence results from a shared patterning mechanism
that utilizes Semaphorin3A and Neuropilin-1. Dev Biol. 255:77–98.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Serini G, Valdembri D, Zanivan S, Morterra
G, Burkhardt C, Caccavari F, Zammataro L, Primo L, Tamagnone L,
Logan M, et al: Class 3 semaphorins control vascular morphogenesis
by inhibiting integrin function. Nature. 424:391–397. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gomez C, Burt-Pichat B, Mallein-Gerin F,
Merle B, Delmas PD, Skerry TM, Vico L, Malaval L and Chenu C:
Expression of Semaphorin-3A and its receptors in endochondral
ossification: Potential role in skeletal development and
innervation. Dev Dyn. 234:393–403. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fang K, Song W, Wang L, Jia S, Wei H, Ren
S, Xu X and Song Y: Immobilization of chitosan film containing
semaphorin 3A onto a microarc oxidized titanium implant surface via
silane reaction to improve MG63 osteogenic differentiation. Int J
Nanomedicine. 9:4649–4657. 2014.PubMed/NCBI
|
|
27
|
Owen TA, Aronow M, Shalhoub V, Barone LM,
Wilming L, Tassinari MS, Kennedy MB, Pockwinse S, Lian JB and Stein
GS: Progressive development of the rat osteoblast phenotype in
vitro: Reciprocal relationships in expression of genes associated
with osteoblast proliferation and differentiation during formation
of the bone extracellular matrix. J Cell Physiol. 143:420–430.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ducy P, Zhang R, Geoffroy V, Ridall AL and
Karsenty G: Osf2/Cbfa1: A transcriptional activator of osteoblast
differentiation. Cell. 89:747–754. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lian JB, Stein GS, Stein JL and van Wijnen
AJ: Osteocalcin gene promoter: Unlocking the secrets for regulation
of osteoblast growth and differentiation. J Cell Biochem Suppl
30–31. 1–72. 1998.
|
|
30
|
Donzelli E, Salvadè A, Mimo P, Viganò M,
Morrone M, Papagna R, Carini F, Zaopo A, Miloso M, Baldoni M and
Tredici G: Mesenchymal stem cells cultured on a collagen scaffold:
In vitro osteogenic differentiation. Arch Oral Biol. 52:64–73.
2007. View Article : Google Scholar : PubMed/NCBI
|
